Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2
Objectives Angiogenesis occurs during tumor progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). Arsenic trioxide (ATO) shows promising therapeutic potential in advanced HCC. Whether ATO regulates angiogenesis and can be used to prevent tumor progression in...
Main Authors: | Shuying Dong, Zhuxin Li, Jian Kong, Shilun Wu, Jun Gao, Wenbing Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | International Journal of Hyperthermia |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2022.2093995 |
Similar Items
-
Glycation of Tie-2 Inhibits Angiopoietin-1 Signaling Activation and Angiopoietin-1-Induced Angiogenesis
by: Haiyan Zhou, et al.
Published: (2022-06-01) -
Impact of Angiopoietin-2 on Kidney Diseases
by: Mei Li, et al.
Published: (2023-03-01) -
Assessment of peripheral blood concentration of angiopoietin 1, angiopoietin 2 and Tie-2 (a tyrosine kinase receptor) of patients with goitre treated surgically
by: Joanna Kalupa, et al.
Published: (2011-06-01) -
Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma
by: Ji-yan Xie, et al.
Published: (2020-03-01) -
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
by: Bart Vanderborght, et al.
Published: (2020-10-01)